![logo](/logos/IPSC.webp)
Century Therapeutics, Inc.
NASDAQ:IPSC
1.46 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Century Therapeutics, Inc. |
Symbool | IPSC |
Munteenheid | USD |
Prijs | 1.46 |
Beurswaarde | 123,685,360 |
Dividendpercentage | 0% |
52-weken bereik | 1.28 - 5.51 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Gregory Russotti Ph.D. |
Website | https://www.centurytx.com |
An error occurred while fetching data.
Over Century Therapeutics, Inc.
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)